Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,474,241
-
Share change
-
+671,028
-
Total reported value
-
$2,070,457,494
-
Put/Call ratio
-
92%
-
Price per share
-
$106.32
-
Number of holders
-
137
-
Value change
-
+$62,622,733
-
Number of buys
-
82
-
Number of sells
-
58
Institutional Holders of CHINA BIOLOGIC PRODS INC - COM (CBPO) as of Q2 2016
As of 30 Jun 2016,
CHINA BIOLOGIC PRODS INC - COM (CBPO) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,474,241 shares.
The largest 10 holders included
Capital Research Global Investors, Capital World Investors, BAILLIE GIFFORD & CO, FMR LLC, Warburg Pincus LLC, Invesco Ltd., Bank of New York Mellon Corp, Mirae Asset Global Investments Co., Ltd., INDUS CAPITAL PARTNERS, LLC, and BlackRock Fund Advisors.
This page lists
137
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.